MSI2 / RNA-binding protein Musashi homolog 2 · Western blot design guide

Design a Western Blot for MSI2

Source-linked MSI2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MSI2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for MSI2: expected band ~35.2 kDa, hero antibody A02898-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable MSI2 Western blot protocol sheet — expected band ~35.2 kDa, antibody A02898-2, controls and PMC citations. Open the full MSI2 WB guide →

MSI2 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~35.2 kDa
Observed band ~35 kDa
Gel 10% (catalog A02898-2)
Positive control ⓘ Adrenal gland (IHC candidate; verify WB) +4 more
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Acetylated
Caveat Modification-state controls
Gene-set association MSigDB C7 membership
Isoform 3 isoform(s)
Section 1

Source-Linked MSI2 Western Blot Protocol Options

The A02898-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman SH-SY5Y, human RT4, human U251, human HepG2, rat brain, rat C6, mouse brain, mouse Neuro-2a (catalog A02898-2)
Gel %10% (catalog A02898-2)
Load30 ug; reducing conditions (catalog A02898-2)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02898-2)
Membranenitrocellulose membrane (catalog A02898-2)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A02898-2)
Primary antibodyA02898-2 · 0.5 μg/mL (catalog A02898-2)
Primary incubationovernight at 4°C (catalog A02898-2)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A02898-2)
Secondary incubation1.5 hour at RT (catalog A02898-2)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A02898-2)
DetectionECL (catalog A02898-2)
Section 2

What Is the Expected MSI2 Western Blot Band Size?

MSI2 is predicted at 35.2 kDa and observed at ~35 kDa; the small difference has no established cause, and band identity needs controls.

What am I looking at on my blot?
Band at ~35 kDaMatches the empirical MSI2 band and its 35.2 kDa predicted mass; confirm identity with controls
Additional bands at different positionsCould reflect isoforms 1, 2, or 3; their migration is not established
Close doublet near 35 kDaCould reflect phosphorylation, but a visible shift has not been demonstrated
Faint ~35 kDa band in whole-cell lysateCytoplasmic MSI2 may be poorly detected in this preparation
💡Expected MSI2 appearanceMSI2 has a predicted mass of 35.2 kDa and an empirical band at ~35 kDa; confirm band identity with a positive control or MSI2 depletion.
How each factor affects band size
Predicted MSI2 mass35.2 kDa predicts migration near the empirical ~35 kDa band
Isoforms 1, 2, and 3May differ in size, but their masses and resolvable migration are not supplied
Phosphoserine at position 6 and annotated position 261May alter mobility; no visible shift is established
N-acetylmethionine at position 1Adds a small modification without an established visible shift
Omega-N-methylarginine at position 228 and annotated position 261Adds small modifications without an established visible shift
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateCytoplasmic MSI2 may be poorly recovered or detectedCheck cytoplasmic extraction and run a positive-control lysate
Band higher than expectedA different isoform or modified MSI2 is possible; the cause is unprovenCompare with a positive control and verify identity by MSI2 depletion
Band lower than expectedAn alternative isoform or degradation is possible; neither migration is establishedUse MSI2 depletion and check sample handling
Multiple bandsIsoforms 1, 2, and 3 or modified MSI2 may contributeCheck band identity by MSI2 depletion; compare isoform-specific expression if available
Weak or no signalMSI2 detection in this preparation may be lowVerify loading, transfer, and signal with a positive-control lysate
Fragments below expected sizeMSI2 degradation is possible given its reported ubiquitination and degradationPrepare fresh lysate with protease inhibitors and verify fragments by MSI2 depletion

Sample controls for MSI2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for MSI2 in Western blot, you can use adrenal gland tissue, which shows high HPA expression.
Positive control: Adrenal gland (IHC candidate; verify WB)
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: No HPA tissue is listed as not detected, so use siRNA knockdown or a KO line for a negative control.

HPA tissue expression evidence for MSI2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Adrenal gland glandular cells High Protein (IHC) HPA →
Appendix glandular cells High Protein (IHC) HPA →
Breast glandular cells High Protein (IHC) HPA →
Caudate neuronal cells High Protein (IHC) HPA →
Cerebral cortex glial cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Lymph node non-germinal center cells Low Protein (IHC) HPA →
Adipose tissue adipocytes Medium Protein (IHC) HPA →
Bone marrow hematopoietic cells Medium Protein (IHC) HPA →
Bronchus respiratory epithelial cells Medium Protein (IHC) HPA →
Cerebellum cells in granular layer Medium Protein (IHC) HPA →
Section 3

Advanced MSI2 Western Blot Tips

Deeper troubleshooting and optimisation questions for MSI2, answered from its protein features.

How should MSI2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could MSI2 isoforms produce different bands?
Isoforms · Yes. UniProt lists three isoforms. Isoform 3 lacks canonical residues 1–104; isoforms 2 and 3 replace residues 243–255 and lack residues 256–328. Isoform 2 also replaces residues 1–21. Compare the detected band and antibody epitope with these sequence differences before assigning an isoform.

It can if its epitope lies in a region that isoform lacks or replaces. Isoform 3 lacks canonical residues 1–104; isoforms 2 and 3 lack 256–328 and replace 243–255. Check the antibody epitope against each isoform before interpreting a missing band.
Which MSI2 modifications matter when interpreting bands?
PTM · UniProt annotates N-acetylmethionine at residue 1, phosphoserine at 6, omega-N-methylarginine at 228, and an annotation listing omega-N-methylarginine, N-acetylalanine, and phosphoserine at 261. These are UniProt canonical coordinates; antibody or paper numbering may differ. The annotations do not establish that any modification creates a resolvable band shift.
Does this guide establish induction of MSI2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for MSI2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02898-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should MSI2 bands be quantified across samples?
Quantitation · Choose the band near 35 kDa for canonical MSI2 and apply the same band selection across samples. If additional bands are included, establish that the antibody recognizes the relevant isoforms first: isoforms 2 and 3 have substantial sequence changes. Report whether the measurement represents the canonical band or combined MSI2 signal.
Why does MSI2 run near 35 kDa?
Interpretation · The canonical MSI2 sequence is 328 residues with a predicted mass of 35.2 kDa, consistent with the observed band near 35 kDa. The listed modifications alone do not establish a visible shift or explain any small difference between calculated and apparent mass.

UniProt reports that MSI2 interacts with RHOBTB2 and that this interaction is necessary for MSI2 ubiquitination and degradation. Consider differences in MSI2 abundance when comparing samples with differing RHOBTB2 activity; the feature does not predict a particular band pattern.

First compare their positions with the three annotated isoforms and check whether the antibody epitope is retained. UniProt lists modified residues and RHOBTB2-dependent ubiquitination and degradation, but these features alone cannot identify an unexpected band. No signal peptide, propeptide, or glycosylation sites are listed to support those explanations.
Boster reagents

MSI2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of MSI2 using anti-MSI2 antibody (A02898-2). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human SH-SY5Y whole cell lysates, Lane 2: human RT4 whole cell lysates, Lane 3: human U251 whole cell lysates, Lane 4: human HepG2 whole cell lysates, Lane 5: rat brain tissue lysates, Lane 6: rat C6 tissue lysates, Lane 7: mouse brain tissue lysates, Lane 8: mouse Neuro-2a tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-MSI2 antigen affinity purified polyclonal antibody (A02898-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for MSI2 at approximately 35 kDa. The expected band size for MSI2 is at 35 kDa.
Anti-MSI2 Antibody Picoband®
Cat # A02898-2
Real WB data Western blot analysis of MSI2 expression in T47 D cell lysate.
Anti-MSI2/Musashi 2 Rabbit Monoclonal Antibody
Cat # M02898
Real WB data Western blot analysis of MSI2 in EL4 cell lysate with MSI2 antibody at 1 μg/mL.
Anti-MSI2 Antibody
Cat # A02898

Three the supplier anti-MSI2 antibodies list human, mouse, and rat reactivity and have WB images. A02898-2 reports a band near 35 kDa across named human, rat, and mouse lysates; the other two captions describe single lysates without comparable conditions.

Which to pick: Choose A02898-2 for the most detailed WB example, including sample types and conditions. M02898 shows T47 D cell lysate, while A02898 shows EL4 cell lysate at 1 μg/mL. All three list the same species reactivity.

Source: BosterBio MSI2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.